Why is Sanofi India falling/rising?

As of 29-Aug, Sanofi India Ltd is experiencing a slight decline in its stock price, currently at 5,120.00, reflecting a change of -4.6 or -0.09%. The stock has been trading lower than its moving averages across various time frames, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 42.16% compared to the 5-day average. Over the past year, the stock has generated a return of -24.69%, which is considerably worse than the broader market, as evidenced by the Sensex's return of -2.83% during the same period.
In the broader market context, Sanofi India's short-term performance has been underwhelming, with a 1-week return of -2.25% compared to the Sensex's -1.84%. The company faces challenges such as poor long-term growth, with net sales and operating profit declining over the past five years. Despite having high management efficiency and a low debt-to-equity ratio, the stock is trading at a premium compared to its peers, which may deter potential investors. The recent flat results in net sales and profit before tax further exacerbate concerns about the company's performance, contributing to its overall decline in stock price.